The info from these studies could lead to the advancement of new pharmaceutical medicines and/or drugs with fewer side effects. Sumith A. Kulartne, Ph.D., is the Vice President of Study & Development, On Focus on Laboratories, LLC, West Lafayette, IN . Under his guidance, On Focus on is developing targeted-Near Infra Crimson imaging brokers that detect tumor margins during procedure for cancers and biologics for inflammatory illnesses. On Focus on is conducting multiple scientific trials at Mayo clinics, UPenn, IU Medical School for cancers such as ovarian, lung, prostate, and kidney.Non-GAAP adjusted net income was $1.2 million, a loss of 2 percent from the same period this past year, and excludes charges for stock-based compensation, amortization of bought intangibles, and the goodwill impairment charge in the first quarter 2009. At March 31, 2010, the company had cash and cash equivalents of $4.7 million as compared to $5.4 million at December 31, 2009. Long-term debts was also decreased by $1.5 million through the first quarter, which included a $1.0 million payment in advance of the required repayment schedule.
Fritz H.D., Jonas Hugosson, M.D., Monique J.